Brief Title
Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype
Official Title
Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype
Brief Summary
This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow Edimer Pharmaceuticals to know more about HED/XLHED so that hopefully the investigators can develop a drug to treat this condition. In this study Edimer will retrospectively review and abstract (summarize) medical records of people that have or may have HED/XLHED in order to further understand the natural history and disease characteristics.
Study Type
Observational
Condition
Hypohidrotic Ectodermal Dysplasia
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
11
Start Date
April 2011
Eligibility Criteria
Inclusion Criteria: -Males or females with: 1. the clinical characteristics of HED, including at least two of the following characteristics: a history of decreased sweating;abnormal teeth (fewer permanent teeth, teeth are smaller than average and often have conical crowns);sparseness of scalp and body hair. -OR- 2. genetically confirmed HED or XLHED;
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT01398397
Organization ID
ECP-006
Responsible Party
Sponsor
Study Sponsor
Edimer Pharmaceuticals
Collaborators
National Foundation of Ectodermal Dysplasia
Study Sponsor
, ,
Verification Date
June 2012